0.585
price up icon66.48%   0.2336
after-market Dopo l'orario di chiusura: .54 -0.045 -7.69%
loading
Precedente Chiudi:
$0.3514
Aprire:
$0.565
Volume 24 ore:
14.90M
Relative Volume:
22.32
Capitalizzazione di mercato:
$45.46M
Reddito:
$8.23M
Utile/perdita netta:
$-32.49M
Rapporto P/E:
-1.1038
EPS:
-0.53
Flusso di cassa netto:
$-19.91M
1 W Prestazione:
-30.02%
1M Prestazione:
-28.69%
6M Prestazione:
-37.31%
1 anno Prestazione:
-49.13%
Intervallo 1D:
Value
$0.55
$0.60
Intervallo di 1 settimana:
Value
$0.292
$0.8383
Portata 52W:
Value
$0.292
$1.65

Clearside Biomedical Inc Stock (CLSD) Company Profile

Name
Nome
Clearside Biomedical Inc
Name
Telefono
678-270-3631
Name
Indirizzo
900 NORTH POINT PARKWAY, ALPHARETTA, GA
Name
Dipendente
32
Name
Cinguettio
@clearsidebio
Name
Prossima data di guadagno
2025-03-18
Name
Ultimi documenti SEC
Name
CLSD's Discussions on Twitter

Confronta CLSD con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CLSD
Clearside Biomedical Inc
0.585 27.31M 8.23M -32.49M -19.91M -0.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Clearside Biomedical Inc Stock (CLSD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-18 Downgrade Chardan Capital Markets Buy → Neutral
2025-07-18 Downgrade H.C. Wainwright Buy → Neutral
2025-07-18 Downgrade Stifel Buy → Hold
2024-08-21 Iniziato Chardan Capital Markets Buy
2024-06-25 Iniziato Oppenheimer Outperform
2021-12-15 Ripresa Wedbush Outperform
2021-07-29 Iniziato H.C. Wainwright Buy
2020-05-13 Iniziato ROTH Capital Buy
2019-08-09 Downgrade Needham Buy → Hold
2018-11-05 Downgrade Cowen Outperform → Market Perform
2018-11-05 Downgrade JP Morgan Overweight → Underweight
2018-11-05 Downgrade Stifel Buy → Hold
2018-03-06 Reiterato Needham Buy
2017-05-25 Iniziato JMP Securities Mkt Outperform
2017-02-24 Iniziato JP Morgan Overweight
2016-11-10 Reiterato Needham Buy
2016-10-24 Reiterato Stifel Buy
Mostra tutto

Clearside Biomedical Inc Borsa (CLSD) Ultime notizie

pulisher
Jul 23, 2025

What analysts say about Clearside Biomedical Inc. stockPhenomenal wealth increase - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is Clearside Biomedical Inc. a good long term investmentExceptional portfolio growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Clearside Biomedical stock soars after Health Canada approves XIPERE - Investing.com Australia

Jul 23, 2025
pulisher
Jul 23, 2025

Clearside Biomedical stock soars after Health Canada approves XIPERE By Investing.com - Investing.com UK

Jul 23, 2025
pulisher
Jul 23, 2025

Health Canada approves Clearside’s XIPERE for uveitic macular edema By Investing.com - Investing.com Nigeria

Jul 23, 2025
pulisher
Jul 23, 2025

Clearside Biomedical Announces Approval of XIPERE® - GlobeNewswire

Jul 23, 2025
pulisher
Jul 23, 2025

Breakthrough Eye Treatment XIPERE Secures Major Health Canada Approval for Macular Edema - Stock Titan

Jul 23, 2025
pulisher
Jul 22, 2025

Why Clearside Biomedical Inc. stock attracts strong analyst attentionFree Growth Investment Group - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Clearside exploring options to advance suprachoroidal delivery platform - Eyes On Eyecare

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Clearside Biomedical Inc. stock priceTremendous return on equity - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Clearside Biomedical announces plan to explore strategic alternatives to advance its proprietary suprachoroidal space (SCS) delivery platform and promising ophthalmology pipeline - Eyes On Eyecare

Jul 22, 2025
pulisher
Jul 21, 2025

Analysts Set Clearside Biomedical, Inc. (NASDAQ:CLSD) Target Price at $4.20 - Defense World

Jul 21, 2025
pulisher
Jul 21, 2025

Uncovering the Potential of Clearside Biomedical Inc (CLSD) Stock - investchronicle.com

Jul 21, 2025
pulisher
Jul 21, 2025

Clearside Biomedical (NASDAQ:CLSD) Downgraded by Stifel Nicolaus to "Hold" - MarketBeat

Jul 21, 2025
pulisher
Jul 20, 2025

Chardan Capital Downgrades Clearside Biomedical (NASDAQ:CLSD) to Neutral - Defense World

Jul 20, 2025
pulisher
Jul 19, 2025

What institutions are buying Clearside Biomedical Inc. stock nowFree Stock Trading Signals - beatles.ru

Jul 19, 2025
pulisher
Jul 19, 2025

Clearside Biomedical Inc. Stock Analysis and ForecastFree Stock Index Interpretation - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Published on: 2025-07-18 21:44:13 - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Clearside Biomedical downgraded to Neutral from Buy at H.C. Wainwright - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Health Care Stocks Stumble As Sector Faces Fresh Setbacks - Finimize

Jul 18, 2025
pulisher
Jul 18, 2025

Deal Dispatch: Del Taco Tanks, Tylenol Maker Aches For Change, Joyebells Burns The Pie - Benzinga

Jul 18, 2025
pulisher
Jul 18, 2025

Published on: 2025-07-18 22:42:56 - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

This Verint Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga

Jul 18, 2025
pulisher
Jul 18, 2025

A Quick Look at Today's Ratings for Clearside Biomedical(CLSD.US), With a Forecast Between $0.84 to $3 - 富途牛牛

Jul 18, 2025
pulisher
Jul 18, 2025

Clearside Biomedical downgraded to Neutral from Buy at Chardan - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

This Elevance Health Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga

Jul 18, 2025
pulisher
Jul 18, 2025

CLSD: Downgraded to Neutral by HC Wainwright & Co. | CLSD Stock News - GuruFocus

Jul 18, 2025
pulisher
Jul 18, 2025

Why Clearside Biomedical Inc. stock is on top investor watchlistsHigh Return Stock Alerts - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Chardan Capital downgrades Clearside Biomedical stock rating to Neutral By Investing.com - Investing.com Canada

Jul 18, 2025
pulisher
Jul 18, 2025

Chardan Capital downgrades Clearside Biomedical stock rating to Neutral - Investing.com

Jul 18, 2025
pulisher
Jul 18, 2025

Stifel downgrades Clearside Biomedical stock to Hold on cash concerns By Investing.com - Investing.com Nigeria

Jul 18, 2025
pulisher
Jul 18, 2025

Stifel downgrades Clearside Biomedical stock to Hold on cash concerns - Investing.com Australia

Jul 18, 2025
pulisher
Jul 17, 2025

Clearside Biomedical Downgraded to Hold Amid Strategic and Financial Uncertainties - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Clearside Biomedical downgraded to Hold from Buy at Stifel - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Clearside Biomedical Announces Plan to Explore Strategic - GlobeNewswire

Jul 17, 2025
pulisher
Jul 17, 2025

Alpharetta biomedical company ‘exploring strategic alternatives’ as job cuts loom - The Business Journals

Jul 17, 2025
pulisher
Jul 17, 2025

Clearside Biomedical shares dip after announcing exploration of strategic alternatives - MSN

Jul 17, 2025
pulisher
Jul 17, 2025

Clearside Biomedical to explore strategic alternatives to advance SCS platform - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Citizens JMP downgrades Clearside Biomedical stock rating as company pauses R&D - Investing.com Canada

Jul 17, 2025
pulisher
Jul 17, 2025

Clearside Biomedical's Stock Plummets 25%: Strategic Overhaul or Value Opportunity? - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Needham downgrades Clearside Biomedical stock to Hold on funding challenges - Investing.com Canada

Jul 17, 2025
pulisher
Jul 17, 2025

Clearside Biomedical (CLSD) Downgraded by Needham to Hold | CLSD Stock News - GuruFocus

Jul 17, 2025
pulisher
Jul 17, 2025

Needham downgrades Clearside on ‘disappointing’ decision to explore options - TipRanks

Jul 17, 2025

Clearside Biomedical Inc Azioni (CLSD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):